159 related articles for article (PubMed ID: 31539790)
1. Prostate MRI technical parameters standardization: A systematic review on adherence to PI-RADSv2 acquisition protocol.
Cuocolo R; Stanzione A; Ponsiglione A; Verde F; Ventimiglia A; Romeo V; Petretta M; Imbriaco M
Eur J Radiol; 2019 Nov; 120():108662. PubMed ID: 31539790
[TBL] [Abstract][Full Text] [Related]
2. Imaging Facilities' Adherence to PI-RADS v2 Minimum Technical Standards for the Performance of Prostate MRI.
Esses SJ; Taneja SS; Rosenkrantz AB
Acad Radiol; 2018 Feb; 25(2):188-195. PubMed ID: 29107458
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the compliance with minimum acceptable technical parameters proposed by PI-RADS v2 guidelines in multiparametric prostate MRI acquisition in tertiary referral hospitals in the Republic of Turkey.
Coşkun M; Sarp AF; Karasu Ş; Gelal MF; Türkbey B
Diagn Interv Radiol; 2019 Nov; 25(6):421-427. PubMed ID: 31650967
[TBL] [Abstract][Full Text] [Related]
4. Quality of Prostate MRI: Is the PI-RADS Standard Sufficient?
Sackett J; Shih JH; Reese SE; Brender JR; Harmon SA; Barrett T; Coskun M; Madariaga M; Marko J; Law YM; Turkbey EB; Mehralivand S; Sanford T; Lay N; Pinto PA; Wood BJ; Choyke PL; Turkbey B
Acad Radiol; 2021 Feb; 28(2):199-207. PubMed ID: 32143993
[TBL] [Abstract][Full Text] [Related]
5. Prospective comparison of PI-RADS version 2 and qualitative in-house categorization system in detection of prostate cancer.
Gaur S; Harmon S; Mehralivand S; Bednarova S; Calio BP; Sugano D; Sidana A; Merino MJ; Pinto PA; Wood BJ; Shih JH; Choyke PL; Turkbey B
J Magn Reson Imaging; 2018 Nov; 48(5):1326-1335. PubMed ID: 29603833
[TBL] [Abstract][Full Text] [Related]
6. Comparison of quantitative apparent diffusion coefficient parameters with prostate imaging reporting and data system V2 assessment for detection of clinically significant peripheral zone prostate cancer.
Hassanzadeh E; Alessandrino F; Olubiyi OI; Glazer DI; Mulkern RV; Fedorov A; Tempany CM; Fennessy FM
Abdom Radiol (NY); 2018 May; 43(5):1237-1244. PubMed ID: 28840280
[TBL] [Abstract][Full Text] [Related]
7. Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference.
Vargas HA; Hötker AM; Goldman DA; Moskowitz CS; Gondo T; Matsumoto K; Ehdaie B; Woo S; Fine SW; Reuter VE; Sala E; Hricak H
Eur Radiol; 2016 Jun; 26(6):1606-12. PubMed ID: 26396111
[TBL] [Abstract][Full Text] [Related]
8. Regional Standardization of Prostate Multiparametric MRI Performance and Reporting: Is There a Role for a Director of Prostate Imaging?
Abreu-Gomez J; Shabana W; McInnes MDF; O'Sullivan JP; Morash C; Schieda N
AJR Am J Roentgenol; 2019 Oct; 213(4):844-850. PubMed ID: 31180739
[No Abstract] [Full Text] [Related]
9. Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA.
De Visschere P; Lumen N; Ost P; Decaestecker K; Pattyn E; Villeirs G
Clin Radiol; 2017 Jan; 72(1):23-32. PubMed ID: 27726850
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Prostate Imaging Reporting and Data System versions 1 and 2 for the Detection of Peripheral Zone Gleason Score 3 + 4 = 7 Cancers.
Krishna S; McInnes M; Lim C; Lim R; Hakim SW; Flood TA; Schieda N
AJR Am J Roentgenol; 2017 Dec; 209(6):W365-W373. PubMed ID: 28981356
[TBL] [Abstract][Full Text] [Related]
11. A Systematic Review of the Existing Prostate Imaging Reporting and Data System Version 2 (PI-RADSv2) Literature and Subset Meta-Analysis of PI-RADSv2 Categories Stratified by Gleason Scores.
Barkovich EJ; Shankar PR; Westphalen AC
AJR Am J Roentgenol; 2019 Apr; 212(4):847-854. PubMed ID: 30807218
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Performance of Prostate Imaging Reporting and Data System Version 2 for Detection of Prostate Cancer: A Systematic Review and Diagnostic Meta-analysis.
Woo S; Suh CH; Kim SY; Cho JY; Kim SH
Eur Urol; 2017 Aug; 72(2):177-188. PubMed ID: 28196723
[TBL] [Abstract][Full Text] [Related]
13. Role of PI-RADSv2 with multiparametric MRI in determining who needs active surveillance or definitive treatment according to PRIAS.
Park JJ; Park BK
J Magn Reson Imaging; 2017 Jun; 45(6):1753-1759. PubMed ID: 27783436
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance and reproducibility of T2w based and diffusion weighted imaging (DWI) based PI-RADSv2 lexicon descriptors for prostate MRI.
Benndorf M; Hahn F; Krönig M; Jilg CA; Krauss T; Langer M; Dovi-Akué P
Eur J Radiol; 2017 Aug; 93():9-15. PubMed ID: 28668436
[TBL] [Abstract][Full Text] [Related]
15. All over the map: An interobserver agreement study of tumor location based on the PI-RADSv2 sector map.
Greer MD; Shih JH; Barrett T; Bednarova S; Kabakus I; Law YM; Shebel H; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
J Magn Reson Imaging; 2018 Aug; 48(2):482-490. PubMed ID: 29341356
[TBL] [Abstract][Full Text] [Related]
16. Prospective Evaluation of the Prostate Imaging Reporting and Data System Version 2 for Prostate Cancer Detection.
Mertan FV; Greer MD; Shih JH; George AK; Kongnyuy M; Muthigi A; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
J Urol; 2016 Sep; 196(3):690-6. PubMed ID: 27101772
[TBL] [Abstract][Full Text] [Related]
17. The performance of PI-RADSv2 and quantitative apparent diffusion coefficient for predicting confirmatory prostate biopsy findings in patients considered for active surveillance of prostate cancer.
Nougaret S; Robertson N; Golia Pernicka J; Molinari N; Hötker AM; Ehdaie B; Sala E; Hricak H; Vargas HA
Abdom Radiol (NY); 2017 Jul; 42(7):1968-1974. PubMed ID: 28258355
[TBL] [Abstract][Full Text] [Related]
18. PI-RADS version 2: quantitative analysis aids reliable interpretation of diffusion-weighted imaging for prostate cancer.
Park SY; Shin SJ; Jung DC; Cho NH; Choi YD; Rha KH; Hong SJ; Oh YT
Eur Radiol; 2017 Jul; 27(7):2776-2783. PubMed ID: 27957637
[TBL] [Abstract][Full Text] [Related]
19. Peripheral zone lesions of intermediary risk in multiparametric prostate MRI: Frequency and validation of the PI-RADSv2 risk stratification algorithm based on focal contrast enhancement.
Benndorf M; Waibel L; Krönig M; Jilg CA; Langer M; Krauss T
Eur J Radiol; 2018 Feb; 99():62-67. PubMed ID: 29362152
[TBL] [Abstract][Full Text] [Related]
20. Effects of the addition of quantitative apparent diffusion coefficient data on the diagnostic performance of the PI-RADS v2 scoring system to detect clinically significant prostate cancer.
Moraes MO; Roman DHH; Copetti J; de S Santos F; Agra A; Noronha JAP; Carvalhal G; Neto EJD; Zanon M; Baldisserotto M; Hochhegger B
World J Urol; 2020 Apr; 38(4):981-991. PubMed ID: 31175458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
